Ophthalmology Market Analysis and Reports | Russia Conference Series

Market Analysis - Ophthalmology 2018

Why Moscow?

Moscow  is the capital and most populous city of Russia, with 13.2 million residents within the city limits and 17.1 million within the urban area. Moscow has the status of a Russian federal city.

Moscow is a major political, economic, cultural, and scientific centre of Russia and Eastern Europe, as well as the largest city entirely on the European continent. By broader definitions Moscow is among the world's largest cities, being the 14th largest metro area, the 18th largest agglomeration, the 15th largest urban area, and the 11th largest by population within city limits worldwide. According to Forbes 2013, Moscow has been ranked as the ninth most expensive city in the world by Mercer and has one of the world's largest urban economies, being ranked as an alpha global city according to the Globalization and World Cities Research Network, and is also one of the fastest growing tourist destinations in the world according to the MasterCard Global Destination Cities Index

Moscow is situated on the banks of the Moskva River, which flows for just over 500 km (311 mi) through the East European Plain in central Russia. 49 bridges span the river and its canals within the city's limits. Moscow has a hemiboreal climate with long, cold (although average by Russian standards) winters usually lasting from mid-November through the end of March, and warm summers. Weather can fluctuate widely with temperatures ranging from −25 °C (−13 °F) in the city and −30 °C (−22 °F) in suburbs to above 5 °C (41 °F) in the winter, and from 10 to 35 °C (50 to 95 °F) in the summer.

Moscow's architecture is world-renowned. Moscow is the site of Saint Basil’s Cathedral, with its elegant onion domes, as well as the Cathedral of Christ the Savior and the Seven Sisters. The first Kremlin was built in the middle of the 12th century. Medieval Moscow's design was of concentric walls and intersecting radial thoroughfares. This layout, as well as Moscow's rivers, helped shape Moscow's design in subsequent centuries.

There are 96 parks and 18 gardens in Moscow, including four botanical gardens. There are 450 square kilometres (170 sq mi) of green zones besides 100 square kilometres (39 sq mi) of forests. Moscow is a very green city, if compared to other cities of comparable size in Western Europe and North America; this is partly due to a history of having green "yards" with trees and grass, between residential buildings. There are on average 27 square meters (290 sq ft) of parks per person in Moscow compared with 6 for Paris, 7.5 in London and 8.6 in New York.

Moscow  is the capital and most populous city of Russia, with 13.2 million residents within the city limits and 17.1 million within the urban area. Moscow has the status of a Russian federal city.

Moscow is a major political, economic, cultural, and scientific centre of Russia and Eastern Europe, as well as the largest city entirely on the European continent. By broader definitions Moscow is among the world's largest cities, being the 14th largest metro area, the 18th largest agglomeration, the 15th largest urban area, and the 11th largest by population within city limits worldwide. According to Forbes 2013, Moscow has been ranked as the ninth most expensive city in the world by Mercer and has one of the world's largest urban economies, being ranked as an alpha global city according to the Globalization and World Cities Research Network, and is also one of the fastest growing tourist destinations in the world according to the MasterCard Global Destination Cities Index

Moscow is situated on the banks of the Moskva River, which flows for just over 500 km (311 mi) through the East European Plain in central Russia. 49 bridges span the river and its canals within the city's limits. Moscow has a hemiboreal climate with long, cold (although average by Russian standards) winters usually lasting from mid-November through the end of March, and warm summers. Weather can fluctuate widely with temperatures ranging from −25 °C (−13 °F) in the city and −30 °C (−22 °F) in suburbs to above 5 °C (41 °F) in the winter, and from 10 to 35 °C (50 to 95 °F) in the summer.

Moscow's architecture is world-renowned. Moscow is the site of Saint Basil’s Cathedral, with its elegant onion domes, as well as the Cathedral of Christ the Savior and the Seven Sisters. The first Kremlin was built in the middle of the 12th century. Medieval Moscow's design was of concentric walls and intersecting radial thoroughfares. This layout, as well as Moscow's rivers, helped shape Moscow's design in subsequent centuries.

There are 96 parks and 18 gardens in Moscow, including four botanical gardens. There are 450 square kilometres (170 sq mi) of green zones besides 100 square kilometres (39 sq mi) of forests. Moscow is a very green city, if compared to other cities of comparable size in Western Europe and North America; this is partly due to a history of having green "yards" with trees and grass, between residential buildings. There are on average 27 square meters (290 sq ft) of parks per person in Moscow compared with 6 for Paris, 7.5 in London and 8.6 in New York.

Why to attend?

With members from around the world focused on learning about clinical ophthalmology, this is the single best opportunity to reach the largest assemblage of participants from the ophthalmology community. Conduct workshops, distribute information, meet with current and potential customers, make a splash with a new product line, and receive name recognition at this 3 days event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in field of ophthalmology are hallmarks of this conference.

Target Audience:

  • Neuropharmacology Students, Scientists
  • Neuropharmacology Researchers
  • Neuropharmacology Faculty
  • Medical Colleges
  • Neuropharmacology Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies

Due to high incidence of eye disorders especially amongst geriatrics and increased number of cataract population, the global ophthalmic drugs and device market is set to grow exponentially in the coming years.  The increased number of ophthalmic incidence leads to the production of new ophthalmic devices to treat the sickness and patients are also ready to get operated via ophthalmic surgeries to maintain the health of their eye and vision.

The significant growth of the global ophthalmic drugs and devices market in the past few years is because of the high incidence of eye diseases such as diabetic retinopathy, age related macular degeneration, glaucoma, cataract, vision correction surgery, eye cancer (retinoblastoma), corneal transplantation, retinopathy of prematurity etc.

The global ophthalmology market is very big and the market report is classified into various categories such as, ophthalmology drugs, devices, diagnostic tools, surgical tools and then further classification is done based on the geography, devices, diseases, surgical tools etc.

 

The European Ophthalmology Drugs and Devices Market are valued as a $12.47 billion market in 2016 and are expected to reach a value of $16.63 billion by 2021 at a CAGR of 5.92%.

According to the report the Ophthalmology Diagnostics and Surgical Devices Market (Corneal Topographers, Optical Coherence Tomography, Echography, Specular Microscopes, Cataract, Refractive, Glaucoma and Vitreoretinal Surgery Devices)- Global Industry Study, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global Ophthalmology Devices market was valued at USD26,012.6million in 2012 and projected to touch a market worth USD40,381.6 million in 2019 at a CAGR of 6.6 % from 2013 to 2019.

The European cataract surgery tools and devices market is classified according to the type of products (phacoemulsification devices, intraocular lenses and ophthalmic viscoelastic devices). The highest share of the market is occupied by intraocular lenses in 2014 around 69.9% followed by phacoemulsification devices. The cataract surgery market of European region is expected to grow at a CAGR of 5.9% by 2019.

The major share of cataract surgery devices market is occupied by Germany, followed by France and it is because of high incidence of eye disorders in these regions of Europe. Moreover, government support for cataract surgery also leads to the growth of cataract surgery devices market in Europe.